The score is driven primarily by attractive valuation (low P/E and a dividend yield) and supportive technicals (price above key moving averages with positive MACD). Financial performance is solid on revenue growth and balance sheet strength, but the sharp decline in free cash flow growth and weaker EBIT/EBITDA margins temper the overall rating.
Positive Factors
Revenue growth & margins
Sustained revenue growth and healthy gross and net margins indicate persistent end-market demand and product-level profitability. Over a 2–6 month horizon this supports reinvestment capacity, pricing power resilience, and a stable earnings base that underpins operational planning and shareholder returns.
Improved leverage and equity strength
Reduced leverage and a solid equity ratio strengthen financial flexibility, lowering refinancing and solvency risk. A double-digit ROE shows effective capital deployment. Together these durable balance-sheet improvements enhance ability to fund capex, manage downturns, and execute strategic initiatives without heavy external funding.
Earnings convert to free cash flow
A 0.60 FCF-to-net-income conversion means a substantial portion of reported earnings becomes discretionary cash. This durable cash conversion supports dividends, debt repayment and reinvestment if operating cash is stabilized, providing financial optionality even amid cyclical pressures.
Negative Factors
Sharp free cash flow decline
A steep 35.5% drop in free cash flow growth materially reduces internally available funds for capex, dividends and deleveraging. If driven by structural working-capital strain or rising maintenance/investment needs, the decline can persist and constrain strategic flexibility and balance-sheet repair over several quarters.
Eroding operating margins
Falling EBIT/EBITDA margins point to cost pressure or weaker pricing that compresses core profitability. If margin erosion is structural—due to higher input costs or competitive pricing—it reduces free cash flow potential and limits the company's ability to fund growth or absorb shocks over the medium term.
Low cash efficiency vs. net income
An OCF-to-net-income ratio of 0.23 shows earnings are not translating into cash efficiently. Persistent divergence raises liquidity and sustainability concerns for dividends and capex, potentially forcing external financing or cuts to investment if cash conversion does not improve.
Konoshima Chemical Co., Ltd. (4026) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥17.16B
Dividend Yield2.81%
Average Volume (3M)152.24K
Price to Earnings (P/E)7.8
Beta (1Y)1.10
Revenue Growth0.23%
EPS Growth-8.64%
CountryJP
Employees448
SectorIndustrials
Sector Strength72
IndustryConstruction
Share Statistics
EPS (TTM)49.59
Shares Outstanding9,240,000
10 Day Avg. Volume182,080
30 Day Avg. Volume152,236
Financial Highlights & Ratios
PEG Ratio-0.70
Price to Book (P/B)0.90
Price to Sales (P/S)0.43
P/FCF Ratio6.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Konoshima Chemical Co., Ltd. Business Overview & Revenue Model
Company DescriptionKonoshima Chemical Co.,Ltd. manufactures and sells building materials, chemicals, and ceramics. The company offers residential and non-residential ceramic siding, eaves, gable boards, and refractory panels; and non-combustible building materials for residential and non-residential buildings. It also provides chemicals, such as magnesium oxide, flame retardant magnesium hydroxide, and magnesium carbonate; and functional ceramics. The company was founded in 1917 and is headquartered in Osaka, Japan.
How the Company Makes Moneynull
Konoshima Chemical Co., Ltd. Financial Statement Overview
Summary
Strong revenue growth (9.1%) and stable profitability (net margin 5.23%) support the score, and leverage has improved (debt-to-equity 0.69) with solid ROE (11.06%). Offsetting this, free cash flow growth declined sharply (-35.5%) and EBIT/EBITDA margins have weakened, raising concerns about cash generation and cost pressure.
Income Statement
75
Positive
Konoshima Chemical Co., Ltd. has shown a strong revenue growth rate of 9.1% in the latest year, indicating a positive trajectory in sales. The gross profit margin is healthy at 25.28%, although it has slightly decreased from previous years. The net profit margin is stable at 5.23%, reflecting consistent profitability. However, the EBIT and EBITDA margins have declined, suggesting potential cost pressures or operational inefficiencies.
Balance Sheet
70
Positive
The company's debt-to-equity ratio has improved to 0.69, indicating a reduction in leverage and a stronger equity position. The return on equity is solid at 11.06%, showcasing effective use of shareholder funds. The equity ratio stands at 42.19%, reflecting a stable financial structure. However, the company should continue to monitor its debt levels to maintain financial stability.
Cash Flow
60
Neutral
The free cash flow growth rate has significantly declined by 35.5%, raising concerns about cash generation. The operating cash flow to net income ratio is 0.23, indicating moderate cash flow efficiency. The free cash flow to net income ratio is 0.60, suggesting that a substantial portion of earnings is converted into free cash flow. The company needs to focus on improving its cash flow generation to support future growth.
Breakdown
TTM
Apr 2024
Apr 2023
Apr 2023
Apr 2022
Apr 2021
Income Statement
Total Revenue
25.12B
27.41B
25.97B
23.98B
21.79B
19.78B
Gross Profit
6.65B
6.93B
6.83B
6.74B
6.62B
5.84B
EBITDA
3.60B
3.76B
3.96B
3.51B
3.10B
2.64B
Net Income
1.57B
1.43B
1.62B
1.53B
1.36B
1.09B
Balance Sheet
Total Assets
30.68B
30.80B
29.82B
29.42B
24.74B
18.63B
Cash, Cash Equivalents and Short-Term Investments
1.30B
1.44B
1.17B
2.15B
1.87B
967.00M
Total Debt
9.31B
9.24B
10.44B
7.98B
5.60B
3.09B
Total Liabilities
19.60B
17.83B
17.91B
18.86B
15.37B
10.09B
Stockholders Equity
11.08B
12.96B
11.91B
10.56B
9.37B
8.54B
Cash Flow
Free Cash Flow
0.00
1.86B
-2.25B
-2.36B
-345.00M
1.83B
Operating Cash Flow
0.00
3.09B
3.34B
1.82B
2.06B
3.01B
Investing Cash Flow
0.00
-1.24B
-5.64B
-4.17B
-2.37B
-1.14B
Financing Cash Flow
0.00
-1.59B
1.32B
2.63B
1.22B
-2.35B
Konoshima Chemical Co., Ltd. Technical Analysis
Technical Analysis Sentiment
Positive
Last Price1532.00
Price Trends
50DMA
1766.58
Positive
100DMA
1636.80
Positive
200DMA
1485.01
Positive
Market Momentum
MACD
55.73
Positive
RSI
51.99
Neutral
STOCH
59.71
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4026, the sentiment is Positive. The current price of 1532 is below the 20-day moving average (MA) of 1914.05, below the 50-day MA of 1766.58, and above the 200-day MA of 1485.01, indicating a neutral trend. The MACD of 55.73 indicates Positive momentum. The RSI at 51.99 is Neutral, neither overbought nor oversold. The STOCH value of 59.71 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4026.
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 12, 2026